Stull, Stull & Brody Announces Investigation Relating to Potential Securities Law Violations by BioDelivery Sciences International, Inc. (NASDAQ:BDSI)


NEW YORK, Nov. 3, 2017 /PRNewswire/ — Stull, Stull & Brody today announces it has commenced an investigation of BioDelivery Sciences International, Inc. (“BioDelivery” or the “Company”) (NASDAQ: BDSI) concerning possible violations of federal securities laws.

If you hold BioDelivery stock and you have questions about your legal rights or interests with respect to these matters, please contact Michael Klein, Esq. at Stull, Stull & Brody by e-mail at, by calling toll-free 1-212-687-7230 x147, by fax to 1-212-490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at

You may retain Stull, Stull & Brody, or other counsel of your choice, to represent you. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Beverly Hills.

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

View original content:–brody-announces-investigation-relating-to-potential-securities-law-violations-by-biodelivery-sciences-international-inc-nasdaqbdsi-300549568.html

SOURCE Stull, Stull & Brody

Related Links–brody-announces-investigation-relating-to-potential-securities-law-violations-by-biodelivery-sciences-international-inc-nasdaqbdsi-300549568.html

- Advertisement -